Transparency Market Research
Diabetic Neuropathy Market Size Set to Hit USD 8.5 Billion by 2034 with a 5.5% CAGR, Boosted by Biomarker-based Diagnostics and Stem Cell Therapy – Analysis by Transparency Market Research
September 26, 2024 12:06 ET | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc., Sept. 26, 2024 (GLOBE NEWSWIRE) -- The diabetic neuropathy market (سوق الاعتلال العصبي السكري) was worth US$ 4.6 billion in...
SNS-INSIDER-300X300.jpg
Peripheral Neuropathy Market Size to Surpass US$ 2.38 Billion By 2032, Driven by Rising Diabetes and Nerve Damage Cases | Research by SNS Insider
July 11, 2024 12:52 ET | SNS Insider pvt ltd
Pune, July 11, 2024 (GLOBE NEWSWIRE) -- Peripheral Neuropathy Market Analysis: “The Peripheral Neuropathy Market size was valued at US$ 1.48 billion in 2023, estimated to reach US$ 2.38 billion...
22157.jpg
Diabetic Peripheral Neuropathy Therapeutics Research 2024: Comprehensive Insights about 10+ Companies and 15+ Pipeline Drugs
June 28, 2024 04:34 ET | Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Peripheral Neuropathy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Diabetic Peripheral...
22157.jpg
Comprehensive Diabetic Neuropathy Pipeline Insight Report for 2024 Reveals Progress in Treatment Landscape
June 27, 2024 10:46 ET | Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Neuropathy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An in-depth pipeline insight report has been...
22157.jpg
Chemotherapy Induced Peripheral Neuropathy Drug Pipeline Research 2024: Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
June 26, 2024 09:26 ET | Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An insightful report...
Global Peripheral Nerve Injury Market
Global Peripheral Nerve Injury Market to Surpass USD 3.57 Billion by 2034, Exhibiting a CAGR of 7.76%
May 20, 2024 07:50 ET | Research and Markets
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Global Peripheral Nerve Injury Market" report has been added to ResearchAndMarkets.com's offering.The global peripheral nerve injury market is poised...
22157.jpg
APAC Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis, Market Size and Market Forecast Report 2024-2034
April 30, 2024 07:44 ET | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
Global Diabetic Neuropathy Treatment Market
Global Diabetic Neuropathy Treatment (Peripheral, Autonomic, NSAIDs, Capsaicin, Opioid) Market Size, Share & Trends Analysis Report 2024-2030
April 22, 2024 10:20 ET | Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy),...
Emergen logo.png
Peripheral Neuropathy Market Size Worth USD 8.54 Billion in 2032 | Emergen Research
January 22, 2024 10:57 ET | Emergen Research
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global peripheral neuropathy market size was USD 3.61 Billion in 2022 and is expected to register a revenue CAGR of 9.0% during the forecast period....
neurometrix_rgb.jpg
Recent Publications Demonstrate Utility of DPNCheck® for Identifying High-Risk Diabetes Patients
June 28, 2023 09:00 ET | NeuroMetrix, Inc.
WOBURN, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of two large studies that support the clinical utility of DPNCheck screening in people...